Mesenchymal phenotype of CTC-enriched blood fraction and lymph node metastasis formation potential.
INTRODUCTION: Circulating tumor cells (CTCs) that present mesenchymal phenotypes can escape standard methods of isolation, thus limiting possibilities for their characterization. Whereas mesenchymal CTCs are considered to be more malignant than epithelial CTCs, factors responsible for this aggressiv...
Main Authors: | Aleksandra Markiewicz, Magdalena Książkiewicz, Marzena Wełnicka-Jaśkiewicz, Barbara Seroczyńska, Jarosław Skokowski, Jolanta Szade, Anna J Żaczek |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3977989?pdf=render |
Similar Items
-
Heterogeneity of Mesenchymal Markers Expression—Molecular Profiles of Cancer Cells Disseminated by Lymphatic and Hematogenous Routes in Breast Cancer
by: Marzena Wełnicka-Jaśkiewicz, et al.
Published: (2013-11-01) -
Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer
by: Markiewicz Aleksandra, et al.
Published: (2012-11-01) -
Prognostic significance of ESR1 amplification and ESR1 PvuII, CYP2C19*2, UGT2B15*2 polymorphisms in breast cancer patients.
by: Aleksandra Markiewicz, et al.
Published: (2013-01-01) -
Aggressive Phenotype of Cells Disseminated via Hematogenous and Lymphatic Route in Breast Cancer Patients
by: Aleksandra Markiewicz, et al.
Published: (2018-06-01) -
Clinical and Biological Significance of <i>ESR1</i> Gene Alteration and Estrogen Receptors Isoforms Expression in Breast Cancer Patients
by: Anna Nagel, et al.
Published: (2019-04-01)